Grisactin is an oral antifungal medication used to treat dermatophyte infections of the skin, hair, and nails. It belongs to the class of oral systemic antifungal agents and functions by binding to fungal cell membrane proteins. This binding interferes with ergosterol synthesis, leading to membrane instability and fungal cell death. The drug distributes widely throughout the body, reaching therapeutic concentrations in keratinized tissues where the infection resides. Its pharmacodynamic effect is primarily fungistatic at lower doses but becomes fungicidal with higher concentrations and prolonged exposure. The sustained antifungal activity supports its use in chronic oral treatment regimens for ringworm and related mycoses.

Grisactin is an oral systemic antifungal derived from griseofulvin that is used to treat infections of the skin hair and nails. It exerts its effect by binding to fungal microtubules and disrupting normal microtubule assembly. This binding prevents tubulin polymerization which is essential for fungal cell division. The disruption of cell division stops further spread of the infection and allows the host immune response to eliminate the remaining organisms. Grisactin is absorbed in the gut and accumulates in keratinized tissues where it reaches concentrations that inhibit fungal growth. Its long residence time in these tissues provides sustained antifungal activity even when blood levels are low. Consequently Grisactin is employed clinically as a long-acting treatment for chronic dermatophyte infections.

Grisactin may cause gastrointestinal symptoms such as nausea and diarrhea in some patients. It can also lead to skin reactions including rash or itching. Headache and dizziness are reported side effects that are generally mild. Elevations of liver enzymes have been observed in a small number of cases. Fatigue and muscle aches are less common but have been noted. Most side effects are reversible after discontinuation of the medication.

Grisactin may cause mild gastrointestinal discomfort such as nausea or stomach upset. Some users report occasional diarrhea or abdominal cramping. Headaches and dizziness are reported side effects. Fatigue can occur, especially during the early weeks of treatment. Skin reactions such as rash or mild itching are possible. Photosensitivity to sunlight may develop in some individuals. Elevated liver enzymes are monitored during therapy without symptoms in most cases. Most side effects are temporary and resolve upon discontinuation of the medication.